Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus

Why Did 5-ARIs Receive a Black Box Warning?

Curbside Consult: Episode 4, Part 2

Herbert Lepor, MD, and Danil Makarov, MD, MHS discuss treating lower urinary track symptoms (LUTS). They explain why one of the treatments, 5-ARIs, are no longer approved for chemoprevention by the FDA.

Learn more about Herbert Lepor, MD.

Learn more about Danil V. Makarov, MD, MHS.